24
GOA RETINA FINAL PROGRAM 27-28 MAY 2016 GENOVA
27 May 2016
GOARETINA
FINAL PROGRAM
27
-28
MA
Y 2
01
6
GEN
OVA
Palazzo Ducale is a historical building that throughout the centuries was regarded as the seat of power of the Republic and the Doge’s residence. The first parts of the Palace were built between 1251 and 1275, during the flourishing period of the Republican history of Genoa, while the Torre Grimaldina (also named “Torre del Popolo” - Tower of the People) was completed in 1539. On the main floor, the so-called Piano Nobile, are the frescoed halls of the Maggior and Minor Consiglio, where many public events take place. Palazzo Ducale was restored in 1992, in occasion of the celebrations of Christopher Columbus and the 500th anniversary of the discovery of America. The palace is today not only a historical building but also a museum and a centre for cultural events and arts exhibitions, the beating heart of cultural and social activities of Genoa and its territory. In July 2001 the Palace hosted the G8 Summit, which was attended by the leaders of Canada, France, Germany, Italy, Japan, Russia, United Kingdom and United States.
WE
LCO
ME
LE
TTE
R
Dear Friends and Colleagues,
We are delighted to welcome you to the GOA_retina Course in Genova.
Main topics include degenerative and vascular disease of the retina, macula and vitreo both medical and surgical, from the bed to the benchmark.
High-tech imaging, diagnostic techniques, different treatment approaches and new insights on angiogenesis from basic science will be the focus of the discussion.
We do wish you a productive Course and a wonderful free time in Genova,
Massimo Nicolò Carlo Enrico Traverso Matteo Badino
2
CO
NTE
NTS
Board and Faculty page 3
General Information page 4
Scientific Information page 6
Scientific Program- 27 May 2016 page 7- 28 May 2016 page 9
Patronages page 11
Acknowledgements page 12
Company Profiles page 14
3
BO
AR
D A
ND
FA
CU
LTY
President Carlo Enrico Traverso
Course Director Massimo Nicolò
Scientific SecretariatMatteo Badino
Faculty
Teresio Avitabile - Catania
Claudio Azzolini - Varese
Matteo Badino - Genoa
Maurizio Battaglia Parodi - Milan
Luigi Borgia - Genoa
Francesco Boscia - Sassari
Susan Bressler - Baltimore (USA)
Felice Cardillo Piccolino - Genoa
Gilda Cennamo - Naples
Davide Croce - Castellanza
Chiara Eandi - Turin
Ettore Ferrari - Imperia
Andrea Giani - Milan
Alfonso Giovannini - Ancona
Michele Iester - Genoa
Ugo Introini - Milan
Silvio Lai - Genoa
Leonardo Mastropasqua - Chieti
Donatella Musetti - Genoa
Piergiorgio Neri - Ancona
Massimo Nicolò - Genoa
Giacomo Panozzo - Verona
Barbara Parolini - Brescia
Mariacristina Parravano - Rome
Grazia Pertile - Negrar
Luisa Pierro - Milan
Alessandra Puddu - Genoa
Giuseppe Querques - Milan
Michele Reibaldi - Catania
Federico Ricci - Rome
Stanislao Rizzo - Florence
Raffaella Rosa - Genoa
Tommaso Rossi - Genoa
Leopold Schmetterer - Vienna (Austria)
Peter Stalmans - Leuven (Belgium)
Giovanni Staurenghi - Milan
Carlandrea Trillo - Genoa
Francesco Viola – Milan
Stela Vujosevic - Padua
4
GE
NE
RA
L IN
FOR
MA
TIO
N
Organizing Secretariat
Viale Giacomo Matteotti, 750121 Florence - ItalyTel. +39 055 50351Fax +39 055 [email protected]
Registration DeskThe Registration Desk in the Loggiato Maggiore of Palazzo Ducale will be open for registration and information according to the following schedule:Friday 27 May from 7.30 to 18.00Saturday 28 May from 8.00 to 16.30Participants are kindly requested to collect their Course kit and name badge. New registrations are also possible at this desk.
Course VenuePalazzo DucalePiazza Giacomo Matteotti, 9 16123 Genoa - Italy
Name BadgeEach participant will receive a name badge upon check-in at the registration desk. The badge will be the official Course pass and should be worn at all time in order to gain entry into the meeting room.
Registration Fees
Fees (VAT included) On site
Delegates € 330,00
Residents, COT, Nurses* € 90,00* Proof of status is mandatory.
5
GE
NE
RA
L IN
FOR
MA
TIO
N
Registration fees include:• Attendance to all scientific sessions • Coffee breaks • Light lunch on 27 and 28 May• Course kit and name badge• Certificate of attendance • CME Kit
Catering on SiteCoffee breaks during the Course and the light lunch on 27 and 28 May are included in the registration fees.
Certificate of AttendanceRegularly registered participants will receive a certificate of attendance.
InsuranceThe Course Organizers do not assume any liability for personal injuries sustained or loss of, or damage to property belonging to Course participants (or their accompanying persons), either during or as result of the Course. Participants are requested to make their own arrangements with respect to health and travel insurance before departing from their home country.
LanguageThe official language of the GOA_retina Course is English. All participants are encouraged to join discussions, independently of their fluency in English, as the exchange of ideas and critical evaluation of presentations is the main purpose of the Course. Simultaneous translation into Italian will be provided during the sessions in the plenary room.
Wi-FiFree Wi-Fi Internet connection is available in the plenary room and common areas of the Course venue.
6
SCIE
NTI
FIC
INFO
RM
ATI
ON
CME CREDITS (only for Italian participants)I crediti formativi ECM saranno certificati dal Provider OIC srl (n. 2836) secondo il nuovo regolamento approvato dalla Commissione Nazionale per la Formazione Continua il 13 gennaio 2010. L’accreditamento del Congresso sarà effettuato per l’intero evento in un’unica soluzioneI crediti assegnati al Corso sono 2,6 e sono rivolti a Medici Specialisti in Oftalmologia, Medici di Medicina Generale, Ortottisti/Assistenti di Oftalmologia, Farmacisti e Infermieri.La presenza al Corso sarà certificata dalla firma dei registri all’entrata e all’uscita giorno per giorno. L’assenza di una sola delle firme necessarie determinerà l’impossibilità di assegnazione dei crediti.Per completare l’acquisizione dei crediti il partecipante dovrà compilare l’apposita modulistica da ritirare presso il Registration Desk, comprensiva di scheda anagrafica e certificazione di autoapprendimento nonché il questionario di valutazione dell’evento da compilarsi in forma anonima. Slide CentreThe Slide Centre is situated in Sala del Minor Consiglio. The plenary room is equipped with a computer slide projector alone, and no traditional slide or overhead projectors for transparencies are available.It will be not possible to use personal laptops in the meeting room. Speakers are kindly requested to use “PowerPoint” (Windows or OS X Apple) or Keynote for their presentations. The dimensions of the presentation should not exceed 300 MB, videos included.Please use “.gif ” and “.jpg” extensions for images. Other types of extensions will be accepted provided they can be recognized by PowerPoint / Keynote.The use of CD-Rom, pens or memory stick is advisable to ease downloading of presentations, and same should be handed to technicians at the Slide Centre in good time. Please remember to collect your CD or memory pen from the Slide Centre at the end of the session.Speakers with presentations on CD Rom or memory pen: please report to the Slide Centre at least one hour before your presentation or the day before if you are scheduled to speak in the morning. Speakers with presentations on personal laptops: please report to the Slide Centre at least four hours before your presentation or the day before, if sched-uled in the morning.This timing will allow your presentation to be downloaded onto the main com-puter.
27 May 2016
7
SCIE
NTI
FIC
PR
OG
RA
M
9.00 Session I - MACULAR IMAGING AND BASIC SCIENCES 13.00 Chairman: Felice Cardillo Piccolino Moderators: Luigi Borgia, Michele Iester, Massimo Nicolò
9.00 Definition of the retinal layers using a common terminology Giovanni Staurenghi
9.20 Swept-source angio-OCT basics and definition of a new OCT generation
Raffaella Rosa
9.40 Angio-OCT basics and definition Gilda Cennamo
10.00 Back to basic science. VEGF and PlGF Alessandra Puddu
10.20 KEYNOTE LECTURE Protocol T: news, results and practical implications
Susan Bressler
10.50 OPENING CEREMONY
11.20 Coffee break
Chairman: Giovanni Staurenghi Moderators: Teresio Avitabile, Ettore Ferrari
11.50 KEYNOTE LECTURE The pipeline in diagnosis. What do we expect Leopold Schmetterer
12.20 Read and understand the pathologic signs at angio-OCT Luisa Pierro
12.40 Management of exudative maculopathy: a focus on idiopathic polypoidal choroidal vasculopathy Alfonso Giovannini
13.00 Light lunch
27 May 2016
8
SCIE
NTI
FIC
PR
OG
RA
M
14.00 Session II - IMPROVEMENT IN VITREO-RETINAL SURGERY18.00 Chairman: Stanislao Rizzo Moderators: Matteo Badino, Silvio Lai, Carlandrea Trillo
14.00 Improvements in vitrectomy instrumentation Tommaso Rossi
14.20 Imaging the vitreoretinal interface with new generation OCT Michele Reibaldi
14.40 High-res imaging of the macula after translocation Grazia Pertile
15.00 Myopic traction maculopathy Francesco Viola
15.20 KEYNOTE LECTURE Inner limiting membrane peeling: is it worth? Leonardo Mastropasqua
15.50 Coffee break
16.10 Prognostic factors in macular pucker Matteo Badino
16.30 The surgery of diabetic macular edema: why and when Francesco Boscia
16.50 Epiretinal prosthesis indications, techniques and results Stanislao Rizzo
17.10 High-res imaging of macular buckling Barbara Parolini
17.30 KEYNOTE LECTURE Episcleral surgery vs. vitrectomy Teresio Avitabile
28 May 2016
9
SCIE
NTI
FIC
PR
OG
RA
M
9.00 Session III - HOW ANGIO-OCT, HIGH-RES IMAGING, NEW LASER13.30 TECHNOLOGY AND PHARMACOTHERAPY WILL CHANGE THE WAY WE MANAGE RETINAL DISEASES Chairman: Giuseppe Querques Moderators: Ugo Introini, Massimo Nicolò
9.00 The evolution of laser photocoagulation: once upon a time the argon Chiara Eandi
9.15 Subthreshold laser: basics and clinical results Stela Vujosevic
9.30 KEYNOTE LECTURE Retinal pigment epithelium and surroundings Felice Cardillo Piccolino
10.00 Adaptive optics Mariacristina Parravano
10.15 Retinal vein and arterial occlusion Maurizio Battaglia Parodi
10.30 Central serous chorioretinopathy Massimo Nicolò
10.45 The burden of macular disease in ageing Europe: costs vs human suffering
Davide Croce
11.05 Discussion
11.15 Coffee break
11.35 KEYNOTE LECTURE New frontiers for enzymatic vitreolysis: indications and results Peter Stalmans
12.05 Choroiditis Piergiorgio Neri
12.20 Wet AMD Giuseppe Querques
28 May 2016
10
SCIE
NTI
FIC
PR
OG
RA
M
9.00 Session III (cont.)13.30
12.35 Atrophic AMD Andrea Giani
12.50 DME and diabetic retinopathy Federico Ricci
13.05 e-health in vitreoretinal disease Claudio Azzolini
13.20 Discussion
13.30 Light lunch
14.30 Session IV - WORKSHOP ON DRUG DELIVERY SYSTEM OF STEROIDS16.30 IN DIABETIC MACULAR EDEMA Chairmen: Giuseppe Querques, Stela Vujosevic
14.30 Role of inflammation in DME Stela Vujosevic
14.45 Anatomic and functional improvement: 3 years of the MEAD study Giuseppe Querques
15.00 The FAME study Donatella Musetti
15.15 Towards a treatment algorithm Maria Cristina Parravano
15.30 Dexamethasone intravitreal implant at the time of cataract surgery in patients with diabetic macular edema Giacomo Panozzo
15.45 Changing indications in the vitrectomized patient Matteo Badino
16.00 Real-life in the management of DME patients Massimo Nicolò
16.15 Discussion
16.30 Closure of the Course
Under the Patronage of
11
PATR
ON
AG
ES
12
AC
KN
OW
LED
GE
ME
NTS
The GOA_retina Course would like to acknowledgethe generous support of the following companies:
14
CO
MPA
NY
PR
OFI
LES
ALCON ITALIA spaCategory: Chemical - PharmaceuticalViale G. Richard, 1/B - 20143 MilanoTel. +39 02818031 - Fax +39 028910550
Alcon aims to be the first choice in eye care sector, by providing innovative products which improve the quality of your sight and life. Alcon is composed by three franchises. Surgical, global leader in the area of ophthalmology surgical tools. Pharma: which offers a broad selection of pharmacologi-cal treatments for eye diseases. Vision Care: leader in the contact lenses market.
ALLERGAN PHARMACEUTICAL IRELANDCategory: Medicines and Medical DevicesTherapeutic area: OphtalmologyVia Salvatore Quasimodo, 134-136 - 00144 RomaTel.+39 [email protected] - www.allergan.it
Allergan is committed to the development of products for the treatment of numerous eye diseases including glaucoma, dry eye, macular oedema. Our company is based on engagement with our clients and collaboration with doctors and patients, to provide the most innovative treatments and to increase access to therapies. Our growth is the result of investment in research and development, thanks to an annual investment of 1,7 billion dollars.
BAYERCategory: PharmaceuticalViale Certosa 130 - 20156 MilanoTel.+39 0239782222 - Fax +39 023978444www.bayer.it
Bayer is a global company based on innovation, with key competences in Life Sciences, Healthcare and Agriculture. Bayer’s scientific research and innovative products are finalized to improve peo-ple’s life quality everywhere in the world, according to the company’s mission: Science for a Better Life.
MAGENTA FARMACEUTICICategory: PharmaceuticalAccount Marcello SelvaggioVia Leonardo da Vinci, 154 - 20090 Trezzano sul Naviglio (MI)Tel. +39 0245101815 - Fax +39 [email protected] - www.magentafarmaceutici.com
Magenta Farmaceutici is a new Italian company within the ophthalmology sector. Its headquarters are located in Milan and it collaborates with managers who have been working in multinational companies for years. On the Italian territory there are 15 Key Account Retina that are very com-petent and appreciated for the work which is carried out. Magenta has an ambitious program to develop new products and new ophthalmology devices, by collaborating with important European societies.
15
CO
MPA
NY
PR
OFI
LES
NICOX FARMA srlCategory: PharmaceuticalAccount Francesca BeccalliVia Ludovico Ariosto, 21 - 20091 Bresso (MI)Tel. +39 0261036304 - Fax +39 [email protected] - www.nicox.it
Nicox is a new international ophthalmic company, aiming to build a diversified portfolio of thera-peutic products addressing the needs of eyecare practitioners and patients around the world. Ni-cox S.A. is the parent company of the Nicox Group and is based in France. Nicox S.A. has a number of international subsidiaries, including three subsidiaries coming from external growth operations. Nicox Farma (previously called EuPharmed) is Nicox’s Italian commercial subsidiary. Nicox comple-ted the acquisition of EuPharmed in December 2013. Nicox Farma commercializes a broad portfo-lio of ophthalmic pharmaceutical products, medical devices and nutraceuticals in Italy.
NOVARTISCategory: PharmaceuticalLargo Umberto Boccioni, 121040 Origgio - Varese Tel. +39 0296541 - Fax +39 0296542910www.novartis.it
Novartis was founded in 1996, through the merger of Ciba-Geigy and Sandoz, and inherited their historically leading role in the pharmaceutical sector. Since the beginning, the new Group proved itself to be one of the major and most innovative protagonists in the healthcare sector and has been responsible for some of the main pharmaceutical breakthroughs of the last years, such as the development of the first ‘target therapy’ in oncology. Today Novartis is one of the world’s leaders in the healthcare area , and one of the most important players in each of the sectors in which ope-rates: innovative medicines, eye care products, generics and biosimilars. The companies of the Group employ approximately 118,000 full-time-equivalent associates and Novartis’s products are available in more than 180 Countries around the world. The company has a consolidated presence in Italy and plays a leading role in all the major therapeutic areas of the Italian pharmaceutical mar-ket: cardio-metabolic, immunology and dermatology, neuroscience, ophthalmology, oncology and hematology, respiratory.Its headquarters is in Origgio, in the province of Varese. In Italy Novartis is also a highly prominent production company, relying on two large manufacturing sites whose acti-vities are directed to the international markets: Torre Annunziata (NA) and Rovereto (TN).
OOgroupCategory: PharmaceuticalC. Da Molino, 17 - 63833 Montegiorgio (FM)Tel. +39 0734964096 - Fax +39 [email protected] - www.oogroup.it/sooft/home.php
OOgroup is an Italian pharmaceutical group specialized in research and development of dietary supplements, medical devices and medical specialities dedicated to eye care. Retina is one of the areas in which OOgroup is more engaged in. In particular, SOOFT and BIOOS division have been dedicating for a number of years the development of specific formulations based on natural in-gredients able to prevent and delay the progression of degenerative diseases, such as diabetic retinopathy and age-related macular degeneration. SOOFT and BIOOS products aim especially to strengthen the eye microcirculation to prevent and delay retinal haemorrhages and to facilitate the retina’s normal functioning. The OOgroup companies have been pioneers, both in Italy and in Europe, in the area of supplementary feeding aimed at primary and secondary prevention of the most widespread and potentially debilitating retinal diseases.
16
CO
MPA
NY
PR
OFI
LES
SANTEN ITALY srl Category: Pharmaceutical - Medical DevicesVia Roberto Lepetit, 8/10 - 20124 Milano Tel. +39 026200191 - Fax +39 [email protected] - http: //santen.eu/it
Santen is a specialized pharmaceutical company exclusively engaged in the ophthalmicsector. Firstly, Santen achieved a prominent role in the market of ophthalmic preparations in Japan, then it expanded worldwide. Santen has been present in Europe for over20 years and in Italy since 2014. It continues to strengthen its presence in many other countries to guarantee that patients and health professionals have access to their innovative treatments.ments.
SIFI - Società Industria Farmaceutica Italiana spaCategory: Pharmaceutical Account Elisa VecchioVia Ercole Patti, 36 - 95025 Aci S. Antonio (CT)Tel. +39 0957922111 - Fax +39 [email protected] - www.sifigroup.com
SIFI is the leading Italian ophthalmic company, focused on eye care since its foundation in 1935. SIFI designs, manufactures and markets innovative pharmaceutical products, surgical and medical devices. Headquartered in Catania (Sicily), SIFI operates directly in Italy, Romania and Mexico with a staff of more than 330 people worldwide. Since June 2015 SIFI is backed by 21 Investimenti, private equity firm founded by Alessandro Benetton, to support the company’s international expansion and portfolio development strategy.
TECNO INSTRUMENTS srl Category: Medical Instruments and Medical Devices Account Elena TurchiStrada Traversante San Leonardo 13/A - 43122 ParmaTel. +39 0113855962 - Fax +39 [email protected] - www.tecnoinstruments.it
Tecno Instruments srl is a distributor of medical equipment and devices (also dispo-sable) for eye surgery and diagnostics. Tecno Instruments srl is working in Piemonte, Valle d’Aosta, Lombardia and Liguria.
17
CO
MPA
NY
PR
OFI
LES
THÉA FARMA spaCategory: Pharmaceutical Account Caterina D’AlessandroVia Giotto, 36 - 20145 MilanoTel. +39 [email protected]
Thea Farma is the Italian branch of Laboratoires Théa, the first European independent pharmaceutical company specialized in ophthalmology. Our mission is to meet ophtal-mologists and patients’ needs, by offering a broad portfolio of products in several the-rapeutic areas: treatment and prevention of AMD (DMLE), dry eye, glaucoma, eye in-fections and inflammations, allergy and products for the surgical practice. Thea Farma offers cutting-edge technologies (ABAK® System) to ensure products preservation wi-thout using preservatives which can damage the ocular surface.
TOPCON ITALIACategory: Medical Instruments and Medical DevicesViale dell’Industria, 60 - Paderno Dugnano (MI)Tel. +39 [email protected] - www.topcon.it
Topcon, founded in Tokyo in 1932, is a multinational company which includes over 60 af-filiated companies and subsidiaries located all over the world. Topcon’s brand is known and appreciated worldwide as a global leader in the production and sale of diagnostic instrumentation and high quality software for ophthalmology and ptometry: Topcon’s products are renowned in the field of ophthalmology for their quality, reliability and performance. The source of Topcon’s strength is research, development and continual improvement of innovative products, by providing the top quality service that its exigent customers expect from them.
VISUFARMA spaCategory: PharmaceuticalVia Canino, 21 - 00191 RomaTel. +39 [email protected] - www.visufarma.it
Visufarma spa is a pharmaceutical society founded in 1996 in Rome with the purchase of some products of MSD Italia. Widening its products portfolio, it became one of the main Italian pharmaceutical – ophthalmic firms. Nowadays it places on the market 35 products for several eye pathologies and diseases. Over the last years, thanks to 2 products paten-ted at EU level, it started internationalising its ophthalmic portfolio, by signing commer-cial agreements with firms operating outside Italy. Recently Visufarma started operating in dermatology and it is currently marketing 8 products in this area and it also has 6 generic medicine products in its portfolio.
WE HELP MILLIONS OF PEOPLE SEE THE WORLD BETTER
OUR VISIONTo be the most trusted leader in eye care
OUR MISSIONTo provide innovative products that enhance quality of life by helping people see better
OUR VALUES• Focus on eye care
• High quality, innovative products
• Partnership with eye care professionals
• High-performance teams
MPXXX.XX.16
16A1151_GOARetina2016_ADV_A5.indd 1 28/04/16 11:56
FINAL PROGRAM
Entro il 2050 la popolazione over 60raggiungerà i due miliardi di individuinel mondo, rendendo la lotta allemalattie legate all’età una sfida ancorapiù grande.Aiutiamo le persone a rimanere piùsane e attive in età avanzata, sia contrattamenti mirati contro il cancro e
le malattie cardiovascolari, sia consoluzioni per malattie oculari eterapie per i malati di artrite. La vitanon dovrebbe fermarsi a 60 anni.Per scoprire come le nostre innovazioni stanno aiutando amigliorare la vita delle persone,visita il sito www.bayer.com/ari.
PER MOLTILA VITA ATTIVA
TERMINA TROPPO PRESTO
NONPOSSIAMOACCETTARLO
